ergistic Antitumor Activity of Sorafenib in Combination Epidermal Growth Factor Receptor Inhibitors in R orectal and Lung Cancer Cells

Abstract

Download pose: Cancer cell survival, invasion, andmetastasis dependon cancer cell proliferation andon tumored angiogenesis.We evaluated the efficacy of the combination of sorafenib and erlotinib or cetuximab. erimental Design: Sorafenib, erlotinib, and cetuximab, alone or in combination, were tested o in a panel of non–small cell lung cancer (NSCLC) and… (More)

4 Figures and Tables

Topics

  • Presentations referencing similar topics